本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

AN2 Therapeutics, Inc.

1.05
-0.0300-2.78%
盘后1.050.00000.00%13:31 EDT
成交量:6.66万
成交额:7.08万
市值:3,168.45万
市盈率:-0.69
高:1.11
开:1.05
低:1.05
收:1.08
数据加载中...
2024/08/13

超过5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/08/13

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/08/13

重要事件披露

Form 8-K - Current report
2024/08/12

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/08/08

重要事件披露

Form 8-K - Current report
2024/07/03

超过5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/06/25

重要事件披露

Form 8-K - Current report
2024/05/14

季度报告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/05/14

重要事件披露

Form 8-K - Current report
2024/05/14

[修订]年度报告

Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]
2024/04/10

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/03/29

员工持股计划

Form S-8 - Securities to be offered to employees in employee benefit plans
2024/03/29

年度报告

Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2024/03/28

重要事件披露

Form 8-K - Current report
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
2024/02/14

超过5%披露

Form SC 13G - Statement of acquisition of beneficial ownership by individuals
2024/02/12

重要事件披露

Form 8-K - Current report
2024/02/09

超过5%披露

Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]